Comparison of NovoPen 3 and syringes/vials in the acceptance of insulin therapy in NIDDM patients with secondary failure to oral hypoglycaemic agents by Kadiri, A, Chraibi, A, Marouan, F, Ababou, M.R, El Guermai, N, Wadjinny, A, Kerfati, A, Douiri, M, Bensouda, J.D, Belkhadir, J, Arvanitis, Y

Get full text